#AANAM – Caregivers Tie Fintepla to Quality-of-life Improvements

#AANAM – Caregivers Tie Fintepla to Quality-of-life Improvements

292282

#AANAM – Caregivers Tie Fintepla to Quality-of-life Improvements

Caregivers of children with Dravet syndrome who are taking Fintepla (fenfluramine) report sustained seizure reductions and quality-of-life improvements, among other benefits, according to a recent study. These findings were presented as a poster titled “Caregivers’ Perspectives on the Long-term Seizure- and Non-seizure-related Benefits of Fenfluramine on Patients with Dravet Syndrome and Their Families,” at the 2021 American Academy of Neurology virtual meeting, held online April 17–22. “The impact of Dravet syndrome on the lives of the…

You must be logged in to read/download the full post.